Skip to main navigation Skip to search Skip to main content

A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF AVELUMAB IN COMBINATION WITH STANDARD OF CARE CHEMORADIOTHERAPY (CISPLATIN PLUS DEFINITIVE RADIATION THERAPY) VERSUS STANDARD OF CARE HEMORADIOTHERAPY IN THE FRONT-LINE TREATMENT OF PATIENTS WITH LOCALLY ADVANCE

Project: Research project

Project Details

StatusFinished
Effective start/end date1/20/17 → 1/19/19

Funding

  • Pfizer, Inc ( Award # ): $10,500.00